RetractedArticleCancer research2013

Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.

Jun Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.